Codon Capital
Overview
Codon Capital is a venture capital firm that brings entrepreneurs and researchers to discover strategies for translating innovation into products and startup companies . Founded in 2013, the firm prefers to make investments in biotechnology companies operating in the therapeutics and synthetic biology sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pivot Bio | Apr 2020 | Series C | - |
| Zag Bio | Oct 2025 | Series A | Co-investor |
| AIRNA | Sep 2023 | Series A | Co-investor |
| Ansa Biotechnologies | Apr 2022 | Series A | - |
| Bonum Therapeutics | Nov 2022 | Series A | - |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Codon Capital based?
Headquarters information for Codon Capital is not publicly available.
When was Codon Capital founded?
Codon Capital was founded in 2013.
How many portfolio companies does Codon Capital have?
Codon Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Codon Capital's portfolio?
Portfolio companies visible on Caplight include Pivot Bio, Zag Bio, AIRNA, Ansa Biotechnologies, Bonum Therapeutics.
What was Codon Capital's most recent investment shown here?
Codon Capital's most recent investment in this portfolio sample was in Zag Bio in 2025.
What sectors does Codon Capital focus on?
Codon Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability.
What company stages does Codon Capital focus on?
Codon Capital typically invests at the Early stage.
What is Codon Capital's AUM?
Codon Capital's assets under management are estimated between $50.0M and $100.0M.